Purchase Order 75N93021P00947

The National Institute of Allergy and Infectious Diseases awarded a $26,045.15 firm fixed-price purchase order to Life Technologies Corporation on July 9, 2021, with an ultimate completion date of July 8, 2022. This contract represents an administrative de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), conducted in preparation for the September 30, 2026 closing of the period of availability for these fiscal year funds. The award carries no set-aside designation and involves performance in Finland. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation and headquartered in Grand Island, New York, is a leading provider of biomedical research tools, genetic analysis instruments, reagents, and laboratory equipment to federal agencies.

Life Technologies maintains an extensive federal contracting presence across civilian and defense agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Veterans Affairs. The company specializes in supplying genetic analysis instruments such as Applied Biosystems genetic analyzers and QuantStudio real-time PCR systems, as well as specialized reagents and consumables supporting molecular diagnostics, disease surveillance, and biomedical research. The company has previously received multiple contract awards related to COVID-19 response efforts and currently maintains active indefinite delivery vehicles with the Department of Veterans Affairs for the supply of pathology and laboratory sequencing reagents, demonstrating its critical role in supporting federal genomic testing and precision medicine initiatives.